Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 586 shares at $43.02 ($25K) on 2025-09-11, disclosed to the SEC on 2025-09-12.
Open-market sale of $25k AKRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |
| AKRO | SELL | 2025-06-12 | $269K | — | Filing → |